Journal article · 2021 · Open access

The role of airway remodeling in the pathogenesis and treatment of chronic obstructive pulmonary disease

Nightingale Syabbalo

Journal of Lung Pulmonary & Respiratory Research, 8(3), 96–102 · Published 22 July 2021 · DOI 10.15406/jlprr.2021.08.00259

Open PDFView at the publisherCite this paper

In brief

“The role of airway remodeling in the pathogenesis and treatment of chronic obstructive pulmonary disease” is a 2021 journal article by Nightingale Syabbalo, published in Journal of Lung Pulmonary & Respiratory Research. OpenAlex counts 1 citations as of 21 November 2026. It is open access: the full text is free to read at Journal of Lung Pulmonary & Respiratory Research.

Citations
1
Most cited in
2025 (1)
References
97
Authors
1

Abstract

Chronic obstructive pulmonary disease (COPD) is currently considered the third leading cause of death in the world. COPD represents an important public health challenge and a socio-economical problem that is preventable and treatable. The main cause of COPD is chronic inhalation of cigarette smoke, and other harmful constituents of air pollution, which cause epithelial injury, chronic inflammation and airway remodeling. Airway remodeling is most prominent in small airways. It is due to infiltration of the airways by inflammatory cells, such as neutrophils, eosinophils, macrophages, and immune cells, including CD8+ T-cells, Th1, Th17 lymphocytes, and innate lymphoid cells group 3. Fibroblasts, myofibroblasts, and airway smooth muscle (ASM) cells also contribute to airway remodeling by depositing extracellular matrix (ECM) proteins, which increase the thickness of the airway wall. Activated inflammatory cells, and structural cells secrete cytokines, chemokines, growth factors, and enzymes which propagate airway remodeling. Airway remodeling is an active process which leads to thickness of the reticular basement membrane, subepithelial fibrosis, peribronchiolar fibrosis, and ASM cells hyperplasia and hypertrophy. It is also accompanied by submucosal glands and goblet cells hypertrophy and mucus hypersecretion, and angiogenesis. Epithelial mesenchymal transmission (EMT) plays a key role in airway remodeling. In patients with COPD and smokers, cellular reprograming in epithelial cells leads to EMT, whereby epithelial cells assume a mesencymal phenotype. Additionally, COPD is associated with increased parasympathetic cholinergic activity, which leads to ASM cells hypercontractility, increased mucus secretion, and vasodilatation. Treatment of COPD is intricate because of the heterogeneous nature of the disease, which requires specific treatment of the pathophysiological pathways, such as airway inflammation, ASM cell hypercontractility, and parasympathetic cholinergic hyperreactivity. The Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2020 strategy report recommends personalized approach for the treatment of COPD. However, some patients with COPD are unresponsive to the standards of care. They may require a triple combination of LABA/LAMA/ICS. Single-inhaler triple therapy (SITT), such as fluticasone fuorate/vilanterol/umeclidinium has been shown to significantly improve symptoms and asthma control, reduce moderate and severe exacerbations, and to improve lung function.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Syabbalo, N. (2021). The role of airway remodeling in the pathogenesis and treatment of chronic obstructive pulmonary disease. Journal of Lung Pulmonary & Respiratory Research, 8(3), 96–102. https://doi.org/10.15406/jlprr.2021.08.00259

MLA 9

Syabbalo, Nightingale. “The role of airway remodeling in the pathogenesis and treatment of chronic obstructive pulmonary disease.” Journal of Lung Pulmonary & Respiratory Research, vol. 8, no. 3, 2021, pp. 96–102. https://doi.org/10.15406/jlprr.2021.08.00259.

Chicago

Syabbalo, Nightingale. 2021. “The role of airway remodeling in the pathogenesis and treatment of chronic obstructive pulmonary disease.” Journal of Lung Pulmonary & Respiratory Research 8 (3): 96–102. https://doi.org/10.15406/jlprr.2021.08.00259.

Harvard

Syabbalo, N. (2021) ‘The role of airway remodeling in the pathogenesis and treatment of chronic obstructive pulmonary disease’, Journal of Lung Pulmonary & Respiratory Research, 8(3), pp. 96–102. doi:10.15406/jlprr.2021.08.00259.

IEEE

N. Syabbalo, “The role of airway remodeling in the pathogenesis and treatment of chronic obstructive pulmonary disease,” Journal of Lung Pulmonary & Respiratory Research, vol. 8, no. 3, pp. 96–102, 2021, doi: 10.15406/jlprr.2021.08.00259.

BibTeX

@article{syabbalo2021role,
  title     = {{The role of airway remodeling in the pathogenesis and treatment of chronic obstructive pulmonary disease}},
  author    = {Syabbalo, Nightingale},
  journal   = {Journal of Lung Pulmonary \& Respiratory Research},
  year      = {2021},
  volume    = {8},
  number    = {3},
  pages     = {96--102},
  doi       = {10.15406/jlprr.2021.08.00259},
  url       = {https://doi.org/10.15406/jlprr.2021.08.00259}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research

  • airway remodeling
  • cigarette smoke
  • small airways
  • airway inflammation
  • epithelial-mesenchymal transition
  • mucus hypersecretion
  • subepithelial fibrosis
  • extracellular matrix

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Syabbalo, N. (2021). The role of airway remodeling in the pathogenesis and treatment of chronic obstructive pulmonary disease. Journal of Lung Pulmonary & Respiratory Research, 8(3), 96–102. https://doi.org/10.15406/jlprr.2021.08.00259

How many times has this paper been cited?

1 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Journal of Lung Pulmonary & Respiratory Research: sign in and open the PDF from this page.

Who wrote this paper?

Nightingale Syabbalo.

What is the DOI of this paper?

10.15406/jlprr.2021.08.00259, permanently at https://doi.org/10.15406/jlprr.2021.08.00259. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.